1. Coronavirus Disease 2019 Diagnostics: Key to Africa's Recovery
- Author
-
Sara Baptista, Emmanuel Nepolo, Sanushka Naidoo, Blessing Mbabie Oyedemi, Sara Suliman, Jesse Gitaka, Shymaa Enany, and Repositório da Universidade de Lisboa
- Subjects
Biochemistry & Molecular Biology ,Coronavirus disease 2019 (COVID-19) ,diagnosis ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,RT-PCR ,Disease ,Biology ,medicine.disease_cause ,Diagnostic tools ,Vaccine Related ,Rare Diseases ,COVID-19 Testing ,Biodefense ,Development economics ,Pandemic ,Genetics ,medicine ,Humans ,Molecular Biology ,Lung ,Coronavirus ,screening and diagnosis ,SARS-CoV-2 ,Prevention ,Outbreak ,COVID-19 ,Cell Biology ,General Medicine ,4.1 Discovery and preclinical testing of markers and technologies ,Vaccination ,Detection ,Infectious Diseases ,Emerging Infectious Diseases ,Good Health and Well Being ,Section B: Infectious Diseases: Pathogenesis, Immune Responses, Vaccines, Diagnostics, and the Broad Impact of Them on Society ,Pneumonia & Influenza ,Immunization ,Biochemistry and Cell Biology ,Infection - Abstract
© Copyright 2021, Mary Ann Liebert, Inc., publishers, With the coronavirus disease of 2019 (COVID-19) becoming a full-blown outbreak in Africa, coupled with many other challenges faced on the African continent, it is apparent that Africa continues to need diagnostics to enable case identification and recovery to this and future challenges. With the slow vaccination rates across the continent, reliable diagnostic tests will be in demand, likely for years to come. Thus, access to reliable diagnostic tools to detect the severe acute respiratory syndrome of the coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19, remain a critical pillar to monitor and contain new waves of COVID-19. Increasing the local capacity to manufacture and roll-out vaccines and decentralized COVID-19 testing are paramount for fighting the pandemic in Africa., SS is supported by an award from the Massachusetts Life Sciences Center Accelerating Coronavirus Testing Solutions (A.C.T.S). JG is funded by the African Academy of Sciences (Grants numbers GCA/MNCH/Round8/207/008 and SARSCov2-4-20-010) and the Royal Society, UK, Grant number FLR\R1\201314.
- Published
- 2021